Language : English
Published : 2014-03-09
Pages : 920
Oxford Handbook of Clinical Medicine
Now in its ninth edition, the Oxford Handbook of Clinical Medicine continues to be the definitive pocket-friendly guide to medicine. The culmination over 25 years of experience at the bedside and in the community, this handbook is packed with practical advice, wit, and wisdom. The Oxford Handbook of Clinical Medicine presents clinical information in a clear way that makes it easy to revise, remember, and implement on the ward. It gives reliable advice on what to do, when to do it, and how to do it, with clinical photographs and diagrams that bring theory to life. Uniquely for a medical text, this book weaves history, literature, art, and philosophy into its survey of medicine, casting new light on the specialties and encouraging the reader to see beyond the practical aspects of medicine and adopt a patient-centred approach to care. The Oxford Handbook of Clinical Medicine looks ever, with a more modern design and over 600 colour images and illustrations. The History and Examination chapter has been completely revamped with systematic flowcharts and new illustrations so that it better reflects real bedside practice. The index, cross-references, and references have been overhauled to make them even easier to use. Every chapter has been written with supervision from experts in each field to ensure accuracy, and updated to reflect relevant guidelines from the NHS, NICE, the Resuscitation Council and other key professional bodies. Loved and trusted by generations of doctors, the Oxford Handbook of Clinical Medicine continues to be an indispensable companion for the practice of modern medicine.
About the Author
Murray Longmore is a GP working in Sussex, UK. Ian Wilkinson is Reader in Clinical Pharmacology at the University of Cambridge and an Honorary Consultant Physician in Cambridge, UK. Andrew Baldwin is a GP Registrar working in Sussex, UK. Elizabeth Wallin is a Specialist Registrar in Renal Medicine working in Cambridge, UK.
Pharmaceutical microbiology has a bearing on all aspects of pharmacy, from the manufacture and quality control of pharmaceutical products through to an understanding of the mode of action of antibiotics. Fully revised and restructured, drawing on the contributions of subject experts, and including material relevant to the European curricula in pharmacy, the eighth edition covers: biology of micro-organisms pathogens and host response prescribing therapeutics contamination and infection control pharmaceutical production current trends and new directions Hugo and Russell’s Pharmaceutical Microbiology, a standard text for Schools of Pharmacy for seven editions , continues to be a user-friendly and authoritative guide for both students and practitioners of pharmacy and pharmaceutical microbiology.
New and emerging directions in pharmaceutical research to better treat schizophrenia
Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined.
With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:
- Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment
- Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery
- Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides
With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.
UNDERSTANDING NORMAL AND CLINICAL NUTRITION, Ninth Edition, provides the most current and comprehensive coverage of the fundamentals of nutrition and nutrition therapy for an introductory course. The early chapters focus on “normal” nutrition, including digestion and metabolism, vitamins and minerals, and life cycle nutrition. The later chapters cover “clinical” nutrition–the pathophysiology and nutrition therapy for a wide range of medical conditions. The text integrates practical information and valuable resources to help students apply nutrition knowledge and skills to their daily lives and the clinical setting. Features, such as case studies, “How To” boxes with real-world examples, and study cards, help students apply the material and build their conceptual understanding. Regardless of the students’ background, the consistent level, approachable narrative, and careful explanations in UNDERSTANDING NORMAL AND CLINICAL NUTRITION will engage students and enable them to be actively involved in the field of nutrition.
About the Author
Ellie Whitney, Ph.D. grew up in New York City and received her BA and PhD degrees in English and Biology at Harvard and Washington Universities. She taught at both Florida State University and Florida A&M University, wrote newspaper columns on environmental matters for the TALLAHASSEE DEMOCRAT, and coauthored almost a dozen college textbooks on nutrition, health, and related topics, many of which repeatedly reappear as new editions. She spen three decades exploring outdoor Florida and studying its ecology, and then cowrote PRICELESS FLORIDA: NATURAL ECOSYSTEMS AND NATIVE SPECIES (Pineapple Press, 2004). Now retired, and more concerned about climate change than any other issue, she volunteers full-time for the nonpartisan national nonprofit Citizens Climate Lobby. Kathryn Pinna received her M.S. and Ph.D. in nutrition from the University of California at Berkeley. She has taught nutrition, food science, and human biology courses in the San Francisco Bay Area for over 25 years and has also worked as an outpatient dietitian, Internet consultant, and freelance writer. Her other publications include the textbooks Understanding Normal and Clinical Nutrition and Nutrition for Health and Health Care. She is a registered dietitian and member of the American Society for Nutrition and the Academy of Nutrition and Dietetics. Sharon Rady Rolfes is a registered dietician nutritionist and a founding member of Nutrition and Health Associates, an information resource center that maintains a research database on more than 1,000 nutrition-related topics. She has taught at Florida State University and coauthored several other college textbooks, including UNDERSTANDING NORMAL AND CLINICAL NUTRITION, 10th EDITION. In addition to writing, she serves as a consultant for various educational projects, and volunteers on the board of Working Well, a community initiative dedicated to creating a healthy workforce. A member of the Academy of Nutrition and Dietetics, Ms. Rady Rolfes received her MS in nutrition and food science from Florida State University.
Happy-People-Pills for All explores current theories of happiness while demonstrating the need to develop advanced pharmacological agents for the enhancement of our capacity for happiness and wellbeing.
- Presents the first detailed exploration of the enhancement of happiness
- A controversial yet rigorous argument that demonstrates the moral imperative for the development and mass distribution of ‘happy-pills’, to promote the well being of the individual and society
- Brings together the philosophy, psychology and biology of happiness
- Maps the development of the next generation of positive mood pharmacology
- Offers a corrective to contemporary accounts of happiness